Clinical trial
Study of Focal Ablation of the Prostate With NanoTherm® Therapy System for…
NCT05010759 · MagForce USA, Industry · Terminated
Key facts
| NCT number | NCT05010759 |
|---|---|
| Title | Study of Focal Ablation of the Prostate With NanoTherm® Therapy System for Intermediate-Risk Prostate Cancer |
| Official title | Stage 2B of: A Pivotal, Prospective, Three-Stage, Single-Arm Study of Focal Ablation of the Prostate With NanoTherm® Therapy System for a Limited-Volume, Clinically Localized, Intermediate-Risk Prostate Cancer |
| Lead sponsor | MagForce USA, Industry |
| Status | Terminated |
| Study type | Interventional |
| Conditions | Prostate Cancer |
| Intervention type | Device |
| Interventions | NanoTherm Ablation |
| Enrollment | 3 |
| Start date | Nov 30, 2021 |
| Primary completion | Jul 28, 2023 |
| Completion | Jul 28, 2023 |
| First posted | Aug 18, 2021 |
| Last update posted | Aug 1, 2023 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: